The severity of HF for patients was assessed by the New York Heart Association (NYHA) classification for HF, left ventricular ejection fraction (LVEF), and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP). This evidence concerns the gene NPPB and hydrops fetalis.